ロード中...
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
For in vitro susceptibility tests with cefoperazone and sulbactam (a beta-lactamase inhibitor), 75/30-micrograms disks may be used with the interpretive zone size breakpoints that are currently used for 75-micrograms cefoperazone disks. For dilution tests, a 2:1 ratio of cefoperazone to sulbactam is...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1988
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC266166/ https://ncbi.nlm.nih.gov/pubmed/3343304 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|